These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32739907)

  • 41. Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study.
    Honarjoo M; Kohan S; Zarean E; Tarrahi MJ
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):464. PubMed ID: 31801467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal Serum PLGF, PAPPA, β-hCG and AFP Levels in Early Second Trimester as Predictors of Preeclampsia.
    Duan H; Zhao G; Xu B; Hu S; Li J
    Clin Lab; 2017 May; 63(5):921-925. PubMed ID: 28627818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
    Bian Z; Shixia C; Duan T
    PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblasts.
    Zhang Y; Yang H; Zhang Y; Shi J; Chen R
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):652. PubMed ID: 33109096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
    Gu W; Lin J; Hou Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of first-trimester serum lipid profile in early prediction of preeclampsia and its severity: A prospective cohort study.
    El Khouly NI; Sanad ZF; Saleh SA; Shabana AA; Elhalaby AF; Badr EE
    Hypertens Pregnancy; 2016; 35(1):73-81. PubMed ID: 26829675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of activated Cdc42-associated kinase inhibits human extravillous trophoblast migration and invasion and decreases protein expression of pho-Akt and matrix metalloproteinase.
    Liu Y; Shan N; Yuan Y; Tan B; He C; Tong C; Qi H
    J Matern Fetal Neonatal Med; 2020 Apr; 33(7):1125-1133. PubMed ID: 30282494
    [No Abstract]   [Full Text] [Related]  

  • 50. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
    Akolekar R; de Cruz J; Foidart JM; Munaut C; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):191-7. PubMed ID: 20101671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal Serum Concentrations of Corin, Endoglin, PP13, and sFlt-1 and their Changes with Advancement of Pregnancy and Correlation with Doppler of Uterine Arteries.
    Chalova KI; Pehlivanov BK; Amaliev IG; Amaliev GI; Raycheva RD; Ivanovska MV
    Folia Med (Plovdiv); 2018 Dec; 60(4):558-564. PubMed ID: 31188762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms in decorin regulation of vascular endothelial growth factor-induced human trophoblast migration and acquisition of endothelial phenotype.
    Lala N; Girish GV; Cloutier-Bosworth A; Lala PK
    Biol Reprod; 2012 Sep; 87(3):59. PubMed ID: 22699486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First and second trimester immune biomarkers in preeclamptic and normotensive women.
    Taylor BD; Ness RB; Klebanoff MA; Zoh R; Bass D; Hougaard DM; Skogstrand K; Haggerty CL
    Pregnancy Hypertens; 2016 Oct; 6(4):388-393. PubMed ID: 27939488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia.
    Su YN; Lee CN; Cheng WF; Shau WY; Chow SN; Hsieh FJ
    Obstet Gynecol; 2001 Jun; 97(6):898-904. PubMed ID: 11384693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIF-1α immunohistochemical expression in decidual cells, villous and extravillous trophoblast in placentas from pregnancies complicated with preeclampsia.
    Kosovic I; Prusac IK; Mestrovic Z; Berkovic A; Marusic J; Tomas SZ
    Pregnancy Hypertens; 2020 Jul; 21():176-178. PubMed ID: 32563172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
    Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.